These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12807568)

  • 1. Tardive dyskinesia in elderly patients: an update.
    Goldberg RJ
    J Am Med Dir Assoc; 2003; 4(2 Suppl):S32-42. PubMed ID: 12807568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tardive dyskinesia in elderly patients: an update.
    Goldberg RJ
    J Am Med Dir Assoc; 2002; 3(3):152-61. PubMed ID: 12807659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic-Induced movement disorders in the elderly: epidemiology and treatment recommendations.
    Caligiuri MR; Jeste DV; Lacro JP
    Drugs Aging; 2000 Nov; 17(5):363-84. PubMed ID: 11190417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EPS profiles: the atypical antipsychotics are not all the same.
    Weiden PJ
    J Psychiatr Pract; 2007 Jan; 13(1):13-24. PubMed ID: 17242588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The problem of tardive akathisia.
    Gualtieri CT
    Brain Cogn; 1993 Sep; 23(1):102-9. PubMed ID: 8105819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of movement disorders in adolescent patients with schizophrenia and in relationship to predominantly atypical antipsychotic treatment.
    Gebhardt S; Härtling F; Hanke M; Mittendorf M; Theisen FM; Wolf-Ostermann K; Grant P; Martin M; Fleischhaker C; Schulz E; Remschmidt H
    Eur Child Adolesc Psychiatry; 2006 Oct; 15(7):371-82. PubMed ID: 16648965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.
    Andrew HG
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Side effects of antipsychotic drugs. Avoiding and minimizing their impact in elderly patients.
    Saltz BL; Woerner MG; Robinson DG; Kane JM
    Postgrad Med; 2000 Feb; 107(2):169-72, 175-8. PubMed ID: 10689415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tardive drug-induced extrapyramidal syndromes.
    Marsálek M
    Pharmacopsychiatry; 2000 Sep; 33 Suppl 1():14-33. PubMed ID: 11072762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs].
    Seigneurie AS; Sauvanaud F; Limosin F
    Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment predictors of extrapyramidal side effects in patients with tardive dyskinesia: results from Veterans Affairs Cooperative Study 394.
    Lohr JB; Caligiuri MP; Edson R; Lavori P; Adler LA; Rotrosen J; Hitzemann R
    J Clin Psychopharmacol; 2002 Apr; 22(2):196-200. PubMed ID: 11910266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A descriptive analysis of spontaneous reports of antipsychotic-induced tardive dyskinesia and other extrapyramidal symptoms in the Japanese Adverse Drug Event Report database.
    Saga Y; Chiang CL; Wakamatsu A
    Neuropsychopharmacol Rep; 2024 Mar; 44(1):221-226. PubMed ID: 37884014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burden of tardive dyskinesia secondary to antipsychotic medication use among patients with mental disorders.
    McEvoy J; Park T; Schilling T; Terasawa E; Ayyagari R; Carroll B
    Curr Med Res Opin; 2019 Jul; 35(7):1205-1214. PubMed ID: 30638073
    [No Abstract]   [Full Text] [Related]  

  • 14. Movement disorders associated with neuroleptic treatment.
    Wirshing WC
    J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics?
    Tarsy D; Baldessarini RJ
    Mov Disord; 2006 May; 21(5):589-98. PubMed ID: 16532448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrapyramidal symptoms with atypical antipsychotics : incidence, prevention and management.
    Pierre JM
    Drug Saf; 2005; 28(3):191-208. PubMed ID: 15733025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of tardive dyskinesia and tardive dystonia in African Caribbean patients on long-term antipsychotic treatment: the Curaçao extrapyramidal syndromes study V.
    van Harten PN; Hoek HW; Matroos GE; van Os J
    J Clin Psychiatry; 2006 Dec; 67(12):1920-7. PubMed ID: 17194270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inter-relationships of tardive dyskinesia, parkinsonism, akathisia and tardive dystonia: the Curaçao Extrapyramidal Syndromes Study II.
    van Harten PN; Hoek HW; Matroos GE; Koeter M; Kahn RS
    Schizophr Res; 1997 Aug; 26(2-3):235-42. PubMed ID: 9323356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrapyramidal syndromes in neuroleptic-treated patients: prevalence, risk factors, and association with tardive dyskinesia.
    Muscettola G; Barbato G; Pampallona S; Casiello M; Bollini P
    J Clin Psychopharmacol; 1999 Jun; 19(3):203-8. PubMed ID: 10350026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia.
    Barnes TR; McPhillips MA
    Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S49-57. PubMed ID: 9690971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.